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ABSTRACT 
There is a paucity of in vitro tests to determine 
potential genotoxicity in human beings. In response to 
this need, a modified microculture system was developed in 
order to study micronuclei production in human peripheral 
blood lymphocytes. Phytohemagglutinin (PHA) was added to 
peripheral blood lymphocytes exposed to increasing doses 
of gamma radiation. Results show that neither PHA or 
radiation alone induce micronuclei production above 
background levels. However, PBML exposed to gamma 
radiation followed by incubation with PHA do produce 
micronuclei. A standardized assay measuring micronuclei, 
gamma interferon, and DNA production, and an interpreta-
tion of the mechanism of induction of PBML micronuclei are 
presented. 
To the memory of my father, Saul Harold Rutstein. 
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PREFACE 
The original proposed study for this research project 
was to apply a human lymphocyte micronucleus test to 
assess genotoxic changes due to exposure by dry cleaning 
workers to perchloroethylene, the dry cleaning agent used 
exclusively in the Salt Lake Valley. Perchloroethylene 
vapor is inhaled by workers throughout the dry cleaning 
process. Skin comes in contact with the chemical during 
the transfer of wet clothes from washers to dryers. The 
question that had been proposed was whether dry cleaning 
workers who were routinely exposed to perchloroethylene 
in a manner known to cause absorption of toxic chemicals 
(dermal and inhalation) would have an increased number of 
micronuclei in their peripheral lymphocytes; further, 
that the micronuclei could be shown to be produced in 
response to a specific exposure to a genotoxic agent. 
The need to show such a cause-and-effect relationship 
was due, in part, to the rapid introduction of chemicals 
into our environment. Many chemicals are produced as by-
products of manufacturing processes; others are additives 
to food or medicines. Most chemicals have been almost 
irreversibly incorporated into necessities in our highly 
industrialized society. The ability to monitor potential 
deleterious effects requires sophisticated and selective 
methods at the basic science level. 
Efforts to proceed with the study to measure the 
effect of perchloroethylene were curtailed when it became 
evident that criteria necessary to control and standard-
ize the micronucleus test had not been developed. This 
lack of standardization, which appeared throughout the 
literature, was finally concluded to be due to a cross-
over phenomenon in science, where methodology from one 
discipline is applied to the study of a new phenomenon 
without the knowledge of what are necessary components of 
the experiments. An example of this phenomenon as it 
applies to the micronucleus test is the importance of 
dose-response relationships in the induction of micro-
nuclei with phytohemagglutinin and radiation. Only one 
concentration of phytohemagglutinin was used without 
consideration that increasing or decreasing its concen-
tration would affect micronucleus production. This 
oversight could minimize, maximize, or invalidate data 
that claimed to identify a chemical as genotoxic. 
The goal of the research was redirected to 
standardizing a test that was being widely applied in the 
identification of genotoxic agents. A test was needed 
that would gain wide acceptance so that each laboratory 
did not have its own micronucleus assay with results that 
could not be reproduced by other researchers because of 
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poor methodology. A test was needed that could truly 
measure genotoxic exposure in human beings with easy 
application to large numbers of people. A test was 
needed that was relatively simple to perform and was 
highly reproducible. The following research was 




The detailed observations in the 19th century by John 
Snow documenting the relationship between cholera out-
breaks and sewer-contaminated water in London were the 
beginning of modern epidemiology (Snow, 1855). It is with 
great diligence that industrialized nations have 
established systems to protect people from common 
infectious sources of disease. Development and 
maintenance of clean water supplies are still the goal of 
developing nations, while industrialized nations face new 
threats to health in the form of chemical and physical 
environmental toxicities. No nation is immune from the 
dangers of environmental poisoning as exemplified by the 
extreme morbidity and mortality experienced by the 
residents of Bophal, India (Last, 1986). 
There are two major populations under consideration 
in environmental and occupational medicine. The first is 
the working population that has potential direct or 
indirect exposure to hazardous agents. The second 
population is the often unsuspecting community at large. 
Contamination of water supplies due to a growing variety 
of toxic agents is an example of the ability· of toxic 
materials to affect large numbers of people who are not 
directly exposed to manufacturing or industrial processes. 
There is a need for rapid, accurate tests to identify 
persons with exposure to genotoxic agents prior to the 
development of gross morbidity and mortality. Sister-
chromatid exchange (SCE) has been used to identify 
potential "cancer-causing agents." Recent data suggest 
that the assay is not as specific as once thought 
(Livingston, 1985). SCE is a transposition at one locus 
betheen the sister chromatids of a chromosome and does not 
result in an alteration of the overall chromosome 
morphology (Latt and Schreck, 1980). The test is time-
consuming, expensive to perform, and requires 
sophisticated technical expertise. These constraints have 
rendered the sister-chromatid exchange method impractical 
in field studies of large populations. 
The Ames test is a measure of bacterial mutagenesis 
and is used to identify potential carcinogens. The test 
identifies back mutation to histidine independence of 
histidine mutants of Salmonella typhimurium and can be 
performed with other bacterial strains that are also 
repair-deficient, contain abnormalities in their cell 
walls that make them permeable to carcinogens, and carry 
an R factor, which enhances mutagenesis. The Ames test 
detects carcinogens by preincubating the test substance 
and the activation system with the test organism (Ames, et 
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al., 1973). This test is currently the most widely used 
as a rapid method to detect potential carcinogens but 
suffers from the limitation that it does not measure the 
carcinogenic potential of a substance on the human host 
under usual conditions of exposure. Thus, the Ames test 
may overestimate carcinogenic potential by identifying 
large numbers of substances that have little predicted 
effect. Generation of large 1 ists of "potential" 
carcinogens is self-defeating, because large numbers 
cannot be adequately assessed. 
Animal models are used to measure toxicity and 
carcinogenicity. Exceptional methods expose animals to 
test agents orally, topically, or parenterally (Timbrell, 
1982). Treated animals are monitored for the development 
of illness, disease, birth defects, or other indicators of 
a pathological process. Evidence of adverse effects often 
are apparent only in animals that are treated with 
unrealistically high concentrations of test substances. 
Assays that purport to test the genotoxic potential of a 
substance are similar to the Ames test in that they do not 
readily predict the biological effects of suspected 
carcinogens on humans under realistic conditions of 
environmental exposure. Additionally, animal model 
systems may not accurately predict effects in humans. 
Recognized inadequacies of existing genotoxic test 
methods led Schmid to develop an assay that utilized the 
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development of intracytoplasmic micronuclei in bone marrow 
cells of mice inoculated with test substances (Boller and 
Schmid, 1970; Schmid, 1975). The Micronucleus Test has 
gained rapid acceptance because of its simplicity, the 
relatively short time required to obtain results, and the 
practical importance of a rapid and accurate assay that is 
a marker of environmentally induced chromosomal damage. 
It was apparent from the beginning that the mouse Micro-
nucleus Test could be a useful direct measure of human 
genotoxic changes if an acceptable alternative to bone 
marro~ cells could be found (Matter and Schmid, 1971). 
Circulating peripheral blood lymphocytes obtained by 
routine venipuncture were substituted for bone marrow 
cells and utilized in a variety of circumstances. 
Unfortunately, enthusiasm for the concept fostered 
premature application of an incompletely characterized 
method. The requisite standardization of this analytical 
procedure to compare data between laboratories has not 
been forthcoming. Standardization is critically important 
at this time in light of the many variations in methods 
and results that exist between laboratories and the 
premature adoption of micronucleus formation by 
governmental regulatory agencies and independent 
investigators. 
The human peripheral lymphocyte Micronucleus Test has 
been used in many forms. Investigators have continuously 
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modified both the method and data presentation. 
Currently, none of these methods has addressed centrally 
important issues of standardization and reproducibility. 
Nevertheless, the need for an in vitro measure of 
biological response to a genotoxic agent has stimulated 
continued efforts to modify and improve unstandardized 
assays. The following studies were undertaken in an 
effort to standardize the human peripheral blood 
lymphocyte Micronucleus Test with the intent to determine 
its informative value as an accurate indicator of 
genotoxic exposure. 
1.2 The History of Micronuclei 
Reticulocytes containing nuclear fragments that 
stained dense blue in Wright's stain preparations were the 
first identified micronuclei. These fragments were called 
Howell-Jolly bodies, after identification by Howell in 
1891 (Howell, 1891) and Jolly in 1905 (Jolly, 1905). 
Howell-Jolly bodies represent chromosomal material that 
has been separated from the spindle during an abnormal 
mitosis. They are typically seen in splenectomized 
persons, as well as in those with hemolytic anemia, 
hyposplenism, and megaloblastic anemia (Cecil, 1985). 
The prevalent hypothesis, based primarily on indirect 
evidence, is that micronuclei are formed from acentric 
chromosomal fragments that occur as a consequence of 
chromosomal breaks or spindle dysfunction (Countryman and 
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Heddle, 1976). During mitosis chromosomes proceed to 
spindle formation, where nuclear material lags behind. 
Chromatin-containing material condenses into small 
micronuclear bodies following separation into two daughter 
cells. Micronuclei can be induced with a variety of 
physical and chemical agents whose mode of action appear 
to support this mechanism of formation (Heddle, et al., 
1978). Several investigators have suggested that the 
human mitogen-induced PBML micronucleus is formed 
following the first division. Thereafter, the cell dies, 
since the loss of nuclear material through the formation 
of a micronucleus is incompatible with survival (Heddle 
and Carrano, 1977). 
The presence of micronuclei as an expression of 
chromosomal breakage induced by toxic agents was studied 
by Schmid (1975) and others (Matter and Schmid, 1971; 
Countryman and Heddle, 1976; Heddle, et al., 1978; Maier 
and Schmid, 1976) in the 1970s. The early studies were 
performed with intraperitoneal or subcutaneous injections 
of test substances into mice, followed by examination of 
the bone marrow extracted from the femur. Micronuclei 
were observed in polychromatic erythroblasts on freshly 
prepared slides. Schmid was encouraged by the simplicity 
of the assay, although he warned about technical problems, 
including variation in yield of bone marrow cells and 
subjectivity in quantitating micronuclei due to staining 
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artifacts, and lack of reliability in the quality of the 
preparations. 
The mouse became the animal of choice, because of the 
ease of handling, abundance of animals, and low cost. 
Heddle reports that the spontaneous frequency of 
micronuclei formation varies with species. Micronucleated 
polychromatic erythroblasts in normal mice range between 
1% and 3%, while frequency in rats ranges between 2% and 
6% (Heddle, et al., 1983). Spontaneous frequencies in the 
murine system above 3% are suspected to be the result of 
technical errors within the laboratory. 
Mice have been used to evaluate the ability of 
numerous chemicals to induce micronuclei. Schlegel and 
MacGregor (Schlegel and MacGregor, 1982) injected 
triethylene-malamine intraperitoneally into mice and 
demonstrated that the micronuclei that were induced 
remained in the circulating blood for an average of 30 
days, and that there appeared to be no effective mechanism 
within the mouse for the removal of micronucleated 
erythrocytes. King and Wild (1984) evaluated 
transplacental mutagens for their ability to produce 
micronuclei in the fetus. Cyclophosphamide, procarbazine, 
trenimon, and mitomycin-C were separately injected into 
pregnant mice. Following a 26-hour incubation, the mice 
were sacrificed, fetal blood cells were pooled, and 
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polychromatic erythrocytes were examined for the presence 
of micronuclei. Dose-dependent increases in 
micronucleated erythrocytes were observed with all four 
agents, with up to 30% to 40% micronucleated cells. 
Application of the micronucleus assay to a human 
system expanded its versatility by allowing the study of 
peripheral blood mononuclear leukocytes from persons with 
genetic diseases and environmental exposures to known and 
suspected carcinogens and genotoxins. The technique 
additionally permitted the study of in vitro exposures for 
toxic agents. 
Normally, PBML are nondividing and micronuclei cannot 
be found in nonproliferating cells. This obstacle can be 
overcome, since PBML can be induced to blast transform and 
divide when they are exposed to the addition of mitogens 
such as phytohemagglutinin (PHA) in vitro. Unlike the 
murine system, the use of human PBML system requires much 
greater standardization, because of the need to culture 
the cells for up to 96 hours in a sterile, physiologic 
environment. The murine system examined cells immediately 
following removal from the mouse and did not use mitogens 
to induce proliferation. Researchers using the human 
mitogen-induced PBML system independently modified their 
methods. Such modifications often emphasized ease of 
performance but ignored issues of reproducibility. A 
brief recounting of the extremes of some of these 
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methodologic changes illustrates their confounding nature 
on reproducibility and, ultimately, on the 
interpretability of results. 
In some cases PHA was added to unfractioned 
anticoagulated blood. Cells were not counted and the 
amount of PHA varied (Pineu, et al., 1984; Fenech and 
Morley, 1985a; Hogstedt, 1984; Fenech and Morley, 1985b). 
Other investigators separated whole blood into erythrocyte 
and PBML fractions on a Ficoll-Hypaque gradient. Isolated 
PBML were divided into two aliquots and placed in culture 
in volumes ranging from 1 ml to 10 mI. The actual number 
of PBML was unknown, since cells were not counted prior to 
being placed in culture. A variety of staining techniques 
were used (Pincu, et al., 1984; Hogstedt, 1984). Heddle 
began using a hypotonic saline solution that not only made 
micronucleated cells more visible but, also, increased the 
amount of cell debris and artifacts in the culture 
(Heddle, et al., 1983). Countryman and Heddle treated 
cultured PBML with radiation and mitomycin-C (1976). 
Increased numbers of micronuclei were reported when PBML 
were obtained from patients following diagnostic x-ray, 
and another study by Stich demonstrated increased 
frequency of micronuclei in the buccal mucosa of smokers 
(Stich and Rosin, 1983). 
Phytohemagglutinin, which is a mitogen and by 
definition causes lymphocytes to undergo blast 
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transformation and divide, was added in arbitrary 
concentrations. The belief seemed to be that any 
concentration that induced blast transformation and 
subsequent cell division would be adequate. Implied in 
the rationale of inducing cells to divide is that there is 
a measurable increase in DNA synthesis in cells incubated 
with PHA. Use of arbitrary PHA concentrations can result 
in misrepresenting the potency of a genotoxin. Both 
inadequate and excessive PHA can underestimate genotoxic 
potential. Therefore, it is necessary to standardize the 
use and applications of this substance. 
1.3 Phytohemagglutinin as a Mitogen 
Phytohemagglutinin (PHA) is a mitogen extracted from 
the seeds of Phaseolus vulgaris, the red kidney bean. PHA 
was employed in early lymphocyte research to separate 
white cells from whole blood by its powerful and almost 
irreversible agglutinating properties. Nowell later 
discovered that PHA induced blast transformation of 
peripheral blood lymphocytes, many of which proceeded on 
to mitosis and complete cell division (Nowell, 1960). PHA 
is currently available in a range of purities. The most 
widely used is the reagent-grade lyophilized preparation, 
which is relatively inexpensive. PHA is also available in 
a highly purified form, which is more expensive than the 
reagent-grade material. The recommended concentration of 
the lyophilized preparation, 900 ug/ml, is for chromosome 
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analysis (Li and Osgood, 1949) and is excessive for the 
induction of micronuclei. Concentrations of PHA used in 
the many reported micronucleus assays range from a 1% 
solution to 5 ug/ml, and a few papers do not identify the 
concentration of PHA used (King and Wild, 1984; Stich and 
Rosin, 1983). It has been reported that micronuclei can 
be induced with a wide range of concentrations of PHA, and 
micronuclei can be induced in cultures of whole blood as 
well as gradient-separated PBML. Peak micronucleus 
production is reached between 72 and 96 hours (Fenech and 
Morley, 1985a). 
To confirm that the concentration of PHA contributes 
to the induction of micronuclei and that technical 
variations in methodology may misrepresent the true 
response requires systematic testing. An understanding of 
the classic dose-response relationship is important in 
structuring experiments that will compare responses to 
treatments and exposures. Application of the human 
mitogen-induced PBML micronucleus assay without a stand-
ardized and reproducible method is premature and 
misleading. 
Current methods differ significantly in important 
fundamental processes that are assumed to have been 
standardized prior to common use of any procedure. Major 
differences exist in culture conditions, volumes, numbers 
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of cells, concentration, and purity of the critical 
stimulant. Curiously, despite major procedural 
differences, cell assays result in the production of the 
same numbers of micronuclei. 
1.4 Culture Conditions 
The criteria necessary for an assay to be 
reproducible are the following: First, a standard 
concentration of cells must be cultured in a standard 
volume. Second, all reagents must be of standard purity. 
Third, a number of concentrations have to be examined in 
order to identify a dose-response range and maximal 
stimulatory conditions for each experiment. Fourth, each 
variable must have a control. Fifth, comparable methods 
of measuring outcome must be clearly established, which 
include culture times, culture conditions, and 
concentrations of reagents. 
No reports were found in the literature that 
adequately document the influence of the concentration of 
PHA on the production of micronuclei. Obviously, the 
concentration of PHA that is chosen must represent one 
that produces maximum micronuclei formation but does not 
produce toxicity or cell death. The dose, derived through 
experimentation, can be used with confidence in subsequent 
tests. The induction of micronuclei in human peripheral 
blood mononuclear leukocytes (PBML) is possible under a 
variety of culture conditions. The task is to standardize 
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the conditions under which the maximum numbers of 
micronuclei can be produced in order to reliably apply the 
test. Almost without exception, each new investigator has 
found reason to vary the test conditions. Modifications 
have rarely, if ever, been tested for reproducibility, 
comparability, or their relationship to previous methods 
or published data. 
1.5 Other Relevant Measures of Peripheral 
Blood Mononuclear Leukocyte (PBML) 
Function 
A number of tests have been used routinely to measure 
PBML functions. Historically, measurements of the 
incorporation of tritiated thymidine into newly synthe-
sized DNA has been used most frequently to measure 
lymphocyte function. Lymphokine production, such as the 
synthesis of gamma interferon, also is used frequently to 
assess PBML reactivity. In general, most PBML macro-
culture systems have been replaced by microculture 
techniques, which accommodate greater numbers of samples. 
Microcultures also reduce the numbers of cells and volume 
of reagents used in experiments. The utilization of 
Ficoll-Hypaque to achieve gradient separation of PBML has 
yielded highly purified preparations of cells for culture. 
At the time these studies were undertaken, 
micronucleus production had the stated potential of being 
widely applied to the study of human genotoxic exposure 
but was limited by cumbersome methodologies, an absence of 
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standardization, and low numbers of micronuclei that could 
be demonstrated. Based on its appeal as a potential 
successor of the more technically difficult seE assay, the 
Micronucleus Test was already in the process of being 
widely applied to the study of a number of important 
problems and processes. Preventive application of 
multiple potentially noncomparable assays produced data 
that were not comparative. The potential existed for the 
development of a body of knowledge comprised of the 
findings of individual experiments whose results could not 
be compared or verified. Standardization, although an 
amazingly simple concept, had not been developed and 
threatened the progress and credibility of this important 
area of research. 
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2. MATERIALS AND METHODS 




Pan-heparin, preservative free, 10.000 units/ml, 
Abbott Laboratories, Chicago. Illinois 
30 milliliter plastic syringe with 20-gauge needle 
RPMI-1640 medium, Gibco Laboratories, Grand Island, 
New York 
Fetal Bovine Serum (FBS), Hyclone, Logan, Utah 
Ficoll-Hypaque solution, Sigma Pharmaceuticals 
Method: 
Venipuncture is used to obtain 30 ml of heparinized 
blood. The blood-filled syringe is gently rotated to 
prevent clotting, the needle is removed, and the blood 
gently expressed into a sterile 100 ml glass bottle. 
Whole blood is diluted with an equal volume of RPMI-1640 
and swirled. The diluted blood is carefully layered on 
top of the Ficoll-Hypaque in a ratio of 3:1 blood to 
Ficoll-Hypaque, in 15 or 50 ml sterile centrifuge tubes. 
The tubes are placed in a Beckman. model TJ-6 table-top 
centrifuge at 1500 rpm for 30 minutes. Centrifugation 
produces a gradient of blood products with the mononuclear 
leukocytes (lymphocytes and monocytes) concentrated in a 
band at the interface above the red blood cells (Boyum, 
1968). These leukocytes are removed with a 5 ml pipet and 
placed in a 50 ml centrifuge tube. The mononuclear 
leukocytes are diluted and washed twice with RPMI-1640 
containing 17% fetal bovine serum. Following the second 
wash, the PBML are resuspended in 10 ml of complete medium 
(RPMI-1640 with 17% FBS) and counted with a hemocytometer. 
PBML are diluted to a concentration of 2 x 106 /ml in 
complete medium. 
2.2 Peripheral Blood Mononuclear Leukocyte 
Isolation and Micronucleus Assay 
(Livingston, 1985) 
This method was in general use in the laboratory at 
the time the current project was initiated. 
Materials: 
Phytohemagglutinin-PHA-M, Burroughs-Wellcome 
RPMI-1640, Gibco Laboratory, Grand Island, New York 
Fetal Bovine Serum, Gibco Laboratory, Grand Island, 
New York 
Method: 
Whole blood is obtained by venipuncture with a 
green-topped vacutainer tube. The blood is rotated to 
prevent clotting. The cap is removed and the blood is 
diluted with an equal volume of RPMI-1640. The diluted 
blood is pipetted into 15 ml centrifuge tubes in equal 
volumes. Ficoll-Hypaque is gently introduced below the 
blood through a spinal needle attached to a 20 ml syringe. 
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The tubes are centrifuged at 1800 rpm for 30 minutes. The 
concentrated PBML band at the interface above the red 
blood cells is removed with a 5 ml pipet and placed in a 
new centrifuge tube. These PBML are then washed twice 
with RPMI-1640 containing 17% FBS. Following the second 
wash, the cell pellet is suspended in 10 ml complete 
medium containing PHA. The resuspended cells are not 
counted but are divided into two equal aliquots in 15 ml 
centrifuge tubes to which another 5 ml of complete medium 
containing PHA is added to each tube. The tubes are 
capped tightly and placed at an angle in a 37 0 C incubator. 
Following an 88-hour incubation, the cells are 
concentrated in a pellet in their tubes by centrifugation 
at 1000 rpm for 15 minutes. The supernatant medium is 
aspirated, leaving just enough medium to resuspend the 
pellet. Cytocentrifuge slides are prepared by combining 2 
to 5 drops of cells from a Pasteur pipet, 1 drop of 
glycerol, and 2 drops of phosphate-buffered saline (PBS, 
pH 7.45). The slides are spun in a table-top cytocentri-
fuge at 6500 rpm for 5 minutes. 
The slide preparations are dehydrated by being 
immersed in methanol for 3 minutes, followed by immersion 
in Wrights-Giemsa stain for 5 minutes and, then, buffer-
stain solution for 12 minutes. The slides are gently 
washed under tap water, air-dried for 24 hours, and 
mounted with Permount and coverslips. 
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2.3 Quantifying Micronuclei (Livingston, 1985) 
Method: 
Stained slides are microscopically examined under an 
oil immersion objective at 1200X. The entire slide is 
scanned, but only fields containing a micronucleated cell 
are counted. This procedure is repeated until 1000 total 
cells are counted. Duplicate slides are prepared from 
each culture and the results are expressed as the mean of 
the duplicates/1000 cells. 
2.4 Microculture of Peripheral Blood 
Mononuclear Leukocytes--Modified 
Materials: 
96-well microtiter plates, Falcon, Microtest II, 
Fisher Scientific 
Phytohemagglutinin, HA-15, Burroughs-Wellcome 
Beckenham, England 
Gammeter, Isomedix, Inc., Parsippany, New York 
Method: 
PBML are isolated according to the method of Boyum in 
Section 2.1. The cells are then divided into 4 aliquots 
for gamma radiation exposure. A cesium 451 source is 
utilized to irradiate the cells. The source is calibrated 
to deliver 480 rads/min. PBML at their final concentra-
tion of 2 x 10'/ml in 4 ml aliquots are dispensed into 
sterile glass vials and irradiated as follows: 
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a. 200 rads = 0.416 minutes 
b. 100 rads = 0.208 minutes 
c. 50 rads = 0.104 minutes 
d. 0 rads = control 
Using a 1 ml pipet, 0.1 ml volumes containing 
2 x 106 /ml PBML are added to each well of a Falcon 
microtiter plate. PHA, supplied as a 5 mg bottle 
lyophilized product, is reconstituted with RPMI-1640 
without serum. This stock solution is then used to make 
all subsequent dilutions. Aliquots of the PHA solution 
are stored at -70o C. Each 1 ml aliquot is thawed no more 
than twice in order to diminish potential loss of activity 
of the PHA. Final concentrations of PHA utilized in the 
experiments range from 3-400 ug/ml. The volume of PHA 
added to each well is 0.1 ml, regardless of the 
concentration. Control cultures receive 0.1 ml of 
complete medium, RPMI-1640 containing 17% FBS, without 
PHA. Figure 1 describes the procedural steps described in 
this section. 
The microculture plates have 8 horizontal rows of 12 
wells each, as diagrammed in Figure 2. Thus, each row 
contains an entire PHA dose curve, plus a cell control. 
Two microculture plates are required for these multidose 
experiments. Continuing in this fashion, the first 3 
horizontal rows are established with cells that are 
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Figure 2. Sequence of PBML culture preparation (top) and 
schematic for PBML distribution in microculture plates 
for mn, 3HTdr, and gamma-IFN determinations (bottom). 
received 200 rads; and the next 3 rows are cells that 
received 100 rads. The final 2 rows of the first micro-
culture plate and the first row of the second plate 
contain cells that received 50 rads. 
Each of the 3 horizontal rows is further divided so 
that the first row (row A) contains nonirradiated cells in 
duplicate with a complete PHA dose curve and cell control 
to be harvested for micronuclei at the end of the 88-hour 
incubation. The second row of the same subset (row B), 
also contains a complete PHA dose curve and cell control. 
However, 12 hours prior to harvest, 0.1 mCi/well 3HTdr 
(specific activity 20 mCi/mM) is added to the entire row 
of cells and returned to the incubator to complete the 88-
hour incubation. Row C contains the same PHA dose curve, 
plus control, as in Rows A and B, but, following the 
incubation, the supernatants of these cultures are removed 
and frozen pending gamma interferon analysis. This 
protocol is repeated for the next 3 subsets of cells, 
which are exposed to the different amounts of gamma 
radiation. Figures 1 and 2 diagram the protocols for 
isolation of PBML and microculture. 
The microculture plates are placed in a 5% COz-
humidified incubator for 88 hours. All samples are 
prepared in duplicate and, depending upon the protocol, in 
quadruplicate, with a final concentration of cells 
2 x lOs/well, and a final volume of 0.2 mI. 
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2.5 DNA Synthesis: Tritiated Thymidine 
Incorporation into Peripheral Blood 
Mononuclear Leukocyte DNA (Green, 
et al., 1981) 
After a 12-hour incubation with 3HTdr, as described 
in Section 2.3, PBML DNA is isolated on glass fiber 
filters using a multiple automatic sample harvester (MASH, 
Flow Laboratories, McClean, Virginia). Filters are 
transferred to biogamma scintillation vials to which 4 ml 
of Aquasol counting solution is added. Tritiated 
thymidine incorporation into DNA is determined as 
disintegrations per minute in a Beckman Liquid 
Scintillation Counter. 
2.6 Sample Preparation for Quantifying 
Micronuclei 
Following an 88-hour incubation, the appropriate 
wells of cells are gently pipetted with individual Pasteur 
pipets. One drop of cell suspension is placed on a 
cytocentrifuge slide with 1 drop of glycerol and 2 drops 
of phosphate-buttered saline, pH 7.45. Cultures 
containing no or very low concentrations of PHA have 3 
drops of cell suspension added to each slide. The 
increase in cell volume is necessary in cultures 
containing low concentrations of PHA. The entire slide is 
immediately spun in a table-top cytocentrifuge at 6500 rpm 
for 5 minutes. 
Slides are Wrights-Giemsa stained by being immersed 
in methanol for 3 minutes, followed by immersion in stain 
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for 5 minutes and, finally, immersed in a buffer-stain 
solution for 15 minutes. The slides are gently washed 
under tap water, air-dried for 24 hours, and mounted with 
Permount. Staining times varied, depending upon the cell 
concentration and the batch of stain. 
2.7 Quantifying Micronuclei--Modified 
Stained slides are viewed with an oil immersion 
objective at a final magnification of 1000X to 1200X. The 
entire slide is scanned and 1000 cells are counted in 
randomly chosen, but representative, areas. The same 
pattern of scanning is utilized in all experiments. 
Each slide is coded so the reader will not know the 
manner in which the PBML had been treated. Also, the 
micronuclei are differentially counted. This means that 
areas of the slide are selected regardless of whether they 
contain a micronucleated PBML. Once a field is randomly 
chosen, all cells in that field are quantitated, and the 
micronucleated cells are counted separately, but as part 
of the total number of cells. The numbers of micronuclei 
are expressed as a ratio out of 1000 total cells per 
slide. 
The same criteria for counting micronuclei apply to 
all slides and to all experiments: 
a. The cell must be intact; 
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b. The micronuclei must be completely separate from 
the main nucleus, but clearly within the 
cytoplasm; 
c. The micronuclei must be at least 50% smaller 
than the main nucleus; 
d. The reader may not preselect areas that contain 
micronuclei. 
2.8 Gamma Interferon Assay (Yet, et al., 1984) 
Following an 88-hour incubation, supernatant media of 
replicate cultures are removed with a Pasteur pipet. 
Media from duplicate cultures are pooled in 1 dram 
sterile, glass vials, labeled and frozen at -70°C until 
assayed for activity. All gamma interferon determinations 
are made within 1 month from the time the supernatant has 
been removed. 
WISH amnion cells are a continuous cell line of 
normal epithelial origin. They have a consistent morphol-
ogy and a doubling time of approximately 24 hours. These 
cells are easily maintained as monolayers grown in RPMI-
1640 containing 10% FBS. WISH cells can routinely be 
trypsinized from an adherent surface and be dispersed into 
single cells for ease of counting. The cells can then be 
subcultured in microculture wells and grown to confluency 
to serve as indicator cells for interferon activity. 
Microculture plates are initially seeded with 7 x lOt 
WISH cells/well in 0.1 ml volumes. The cells are allowed 
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to grow to confluency, which occurs in 24 hours. Samples 
to be tested for gamma interferon are added in 50 ul 
volumes to the first row of each plate. Serial 1:3 
dilutions are made with a Titer-Tek automatic dilutor 
(Flow Laboratories). Each plate consists of 8 horizontal 
rows and 12 columns. Row 11 of each plate is always a 
virus control, meaning that it contains only virus 
inoculum. Row 12 is always a cell control to which only 
media is added. After the dilutions are made, the plates 
are incubated at 37 0 C for a minimum of 6 hours to allow 
the gamma interferon to maximally activate the WISH cells 
to the antiviral state. Following the 6-hour incubation 
period, WISH cell culture media are decanted, and the cell 
monolayers are washed one time with 0.1 ml of prewarmed 
Eagle Minimal Essential Medium containing 2% FBS. Fresh 
medium containing encephalomyocarditis (EMC) virus is 
added at a ratio of 1 infectious particle per 10 WISH 
cells in 0.1 ml to all wells except the cell controls, 
which received 0.1 ml of virus-free medium. The titer of 
virus had been previously determined and was used by 
several laboratories. The plates are incubated for 
approximately 22 hours at 37 o C, or when 95% of the WISH 
cells in the virus control wells show typical cytopathic 
effect (CPE) when viewed microscopically. Dramatic 
morphologic changes initiated by the virus include diffuse 
granulation, decrease in the size of the cells, appearance 
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of clusters on the monolayer, and loss of characteristic 
WISH cell morphology. 
The medium is decanted, and the entire microculture 
plate is fixed and stained with crystal violet-formalin-
ethanol-saline solution for 15 minutes. The plates are 
then washed under running tap water and air-dried. 
Microculture wells, which contain higher titers of 
interferon and are protected from the virus, stain a dark 
purple, while those cells with little or no interferon are 
colorless. Interferon titers are established by optical 
density reading of the plates using an automated ELISA 
reader (Multiscan, Flow Laboratories) equipped with a 600 
nM filter. Interferon titer is expressed as the 
reciprocal of the dilution of supernatant that inhibits 
EMC-induced cytopathic effect (CPE) by 50%. 
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3. RESULTS 
3.1 Preliminary Experiments 
A series of slides prepared for teaching purposes by 
Dr. Gordon Livingston was used to learn to identify 
micronuclei in PBML exposed to 100-400 R of gamma 
radiation and PHA. Duplicate slides were coded to permit 
impartial, e.g., "blinded." reading of 1000 PBML/slide. 
Dr. Livingston·s techniques were used and microscopic 
fields containing micronucleated cells were selected 
exclusively. The method used to perform these prelimin-
ary experiments is described in Section 3.3. Figures 3 
and 4 show micronuclei counts resulting from my reading 
the teaching slides compared with counts obtained with an 
experienced reader, respectively. The comparable nature 
of the results obtained. with small variations. by the 
two readers indicates that the investigator could count 
micronuclei accurately without further practice. At this 
point, prior to further experimentation, the method was 
altered to eliminate the potential bias that results from 
only selecting areas that contain PBML with micronuclei. 
Preselection of micronuclei containing microscopic fields 
was eliminated, and areas were chosen at random along a 
zig-zag pattern of the slide. Efforts were made to count 





















Figure 3. Micronuclei (mean + S.D.) counts from standard 
















Figure 4. Micronuclei (mean ± S.D.) present in PBML 
exposed to gamma radiation read by a trained reader 
(courtesy G. Livingston). 
PBML not exposed to radiation did not produce 
micronuclei. Total numbers of micronuclei increased with 
the amount of radiation. Both readers observed peak 
micronuclei production at 400 R with a mean of 82.5/1000 
lymphocytes in Figure 3 and 105/1000 lymphocytes in 
Figure 4. Micronuclei production increased in response 
to increased radiation with both readers. The teaching 
slides did not contain a non-PHA control, and the 
concentration of PHA added to the irradiated cells was 
not known. 
Initial experiments did not yield results that can 
necessarily be expressed in numbers of micronuclei. Many 
methodological problems were incurred while trying to 
obtain micronuclei. These problems, and the resulting 
modifications to the existing assay, are as follows: 
First, duplicate cultures became a requisite part of each 
experiment. Second, non-PHA cultures of PBML were added 
as a control. Third, PBML in every experiment were 
adjusted to the same concentration of 2 x lOs/mI. 
Fourth, a graded series of concentrations of PHA were 
added to fixed numbers of PBML following irradiation to 
see if micronuclei production was dependent on the 
concentration of mitogen as well as genotoxin. Fifth, 
numbers of PBML spun onto the cytocentrifuge slide needed 
to be increased in control cultures of PBML that did not 
contain PHA, as well as the cultures with lower 
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concentrations of PHA. Sixth, the large volume of the 
cultures (10 ml in a 15 ml conical centrifuge tube) 
created a potentially harmful pH gradient during incuba-
tion. A microculture system was adapted to the culture 
of PBML for micronuclei, which resulted in a final volume 
of 0.2 mI. 
Figure 5 shows that PBML exposed to 200 Rand 
concentrations of PHA that ranged from 25 ug/ml to 400 
ug/ml produced micronuclei in consistently greater 
numbers than in the nonirradiated control culture 
containing 200 ug/ml PHA. At that concentration of PHA, 
the nonirradiated culture contained 7/1000 lymphocytes, 
while the irradiated counterpart contained 75/1000 
lymphocytes. An apparent dose-related peak in micro-
nuclei production was observed at 100 ug/ml PHA, with a 
mean of 134/1000 cells. The lowest concentration of PHA 
added to irradiated cells was 25 ug/ml, and the 65/1000 
lymphocytes counted at this concentration was 
approximately 9 times higher than that found in the 
nonirradiated control. 
Examination of the cultures following the 88-hour 
incubation period revealed that the pH of the cultures, 
estimated by variation in color of the phenol red 
containing medium, decreased as the concentration of PHA 
increased. The tubes containing the control and low PHA 


















































































































































containing the 200 ug/ml and 400 ug/ml PHA were yellow. 
Several slides were not able to be read because of 
massive blast transformation and cell fragmentation that 
were noticed when PBML were exposed to high concentra-
tions of PHA and 200 R of gamma radiation. Table 1 
presents the previously used method and the modified 
methods that were used in the next experiments. Optimum 
culture conditions were considered to be vitally 
important to this method and it was clear, following 
microscopic examination of the cells, that large volumes 
were not ideal. Modifications listed above, and those 
described in Section 2.7, were used in the remaining 
experiments. These modifications provided the prerequi-
site standardization necessary for the study of the 
induction of micronuclei. 
3.2 Micronuclei Production in Gamma-
Irradiated Peripheral Blood 
Lymphocytes Performed 
in Microculture 
The relationship among radiation exposure, PHA 
concentration, and micronuclei production was examined in 
PBML maintained in microcultures in multiple-well plates. 
Replicate cultures were prepared with PBML that were 
either exposed to 200 R or were nonirradiated. Irradi-
ated and nonirradiated PBML were cultured with PHA 
concentrations ranging from 25 ug/ml to 400 ug/ml. 
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TABLE 1 
COMPARISON OF PREMODIFICATION AND MODIFIED 
MICRONUCLEUS ASSAYS 
Premodification Method 
PBML concentration unknown 
Culture volume 5-15 ml 
Select only micronuclei 
containing PBML fields 
No non-PHA controls 
One concentration of PHA 
PBML incubated in closed 
tubes in 37 0 C incubator 
Modified Method 
PBML concentration fixed 
Culture volume 0.2 ml 
Random fields of PBML 
chosen 
Non-PHA controls in each 
experiment 
Range of PHA 
concentrations 
PBML incubated in 5% CO 
humidified incubator 
at 37 0 C 
The number of micronuclei in irradiated and nonirradiated 
cells is presented in Figure 6. There were no micronu-
clei in cultures without PHA or radiation. A mean of 
5.5/1000 lymphocytes was obtained in the 175 ug/ml of PHA 
cultures. The remainder of the nonirradiated cultures 
produced no greater than 3/1000 lymphocytes, regardless 
of increasing concentrations of PHA. Microscopic 
examination of the nonirradiated PBML revealed cells in 
varying stages of blast transformation that increased in 
number as PHA concentration increased. Small lymphocytes 
were prominent in the cultures PBML containing low 




















































































































































PBML that were irradiated and exposed to varying 
concentrations of PHA produced micronuclei. Irradiated 
cultures to which PHA was not added exhibited extensive 
cell damage, and no micronuclei were found. Stained 
preparations of these cultures contained almost 100% 
small lymphocytes, which were either fragmented, with 
their cytoplasm extruding from the cell, or appeared much 
smaller and more condensed than normal, with no visible 
cytoplasm, or were lysed. Radiation-induced cell damage 
was not seen in slides prepared from cultures that also 
contained PHA. Cultures containing the lowest concentra-
tion of PHA, 25 ug/ml, induced a mean of 29.5/1000 
lymphocytes, and the PBML on these slides appeared 
uniformly healthy. There were many small lymphocytes 
with visible cytoplasm scattered among blast cells, as 
well as small clumps of agglutinated blast cells. 
Micronuclei were visible only in the blast 
transformed cells. Concentrations of PHA in excess of 
100 ug/ml produced variable, but decreasing, numbers of 
micronuclei. In this initial microculture experiment, 
there were wide ranges in micronuclei counts and poor 
duplication. It appears that peak micronuclei production 
occurred between 25 ug/ml and 125 ug/ml PHA. It was not 
clear, at this point, why the curve seemed to follow a 
downward trend with higher concentrations of PHA. 
Increasingly large numbers of blast-transformed cells and 
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agglutination were observed with higher concentrations of 
PHA, and, yet, mean micronuclei counts decreased to 
17.5/1000 lymphocytes at 400 ug/ml PHA. This experiment 
was repeated in an attempt to achieve better duplication 
and to examine the inverse relationship between increas-
ing PHA concentration and decreased in micronuclei 
production. 
Another experiment (Experiment A), which is presented 
in Figure 7, shows more clearly that micronuclei produc-
tion was greatest at the lowest concentration of PHA and 
declined. Slide preparations appeared uniform in cell 
number, and accuracy in duplication increased with 
corrected cell volumes and uniformity of stain. Control 
cultures without irradiation and PHA contained no 
micronuclei. Numbers of micronuclei in nonirradiated 
PBML, regardless of PHA concentration, averaged 3.1/1000 
lymphocytes with a range of 1-5/1000 lymphocytes. 
Maximum numbers of micronuclei, 53/1000 lymphocytes, were 
found in irradiated cultures containing 75 ug/ml of PHA. 
Absolute numbers of micronuclei decreased to a mean of 
15.5/1000 lymphocytes in the cultures containing 400 
ug/ml PHA. Microscopic examination of irradiated cells 
at the higher concentrations of PHA revealed varying 
degrees of cell damage. PBML were considered damaged if 
any or all of the following were observed: broken cell 




























































































































































































cell with lacy cytoplasm, torn nuclear membranes, or 
pyknotic appearance. 
3.3 Micronuclei Formation, DNA Synthesis, 
and Gamma Interferon Production in 
Irradiated and Nonirradiated 
Peripheral Blood Lymphocytes 
The effect of several doses of radiation combined 
with lower concentrations of PHA on micronuclei product-
ion is shown in Figure 8 (Experiment B). There were no 
micronuclei in PBML from control cultures without 
radiation or PHA. Nonirradiated cultures contained no or 
very few micronuclei, with a mean of 1/1000 lymphocytes 
at 100 ug/ml of PHA, and a mean of 2/1000 lymphocytes at 
300 ug/ml of PHA. Microscopic evaluation revealed evenly 
stained, small lymphocytes with only scant blast 
transformation. There was no agglutination at low 
concentrations of PHA, but, as noted in previous experi-
ments, blast transformation and agglutination increased 
with PHA concentration. 
Irradiated PBML began to produce micronuclei at 10 
ug/ml of PHA regardless of dose of radiation, but the 
higher doses of radiation produced greater numbers of 
micronuclei. In the 50 R cultures, maximum micronuclei 
production with a mean of 17.5/1000 lymphocytes at 30 
ug/ml of PHA was reached. The same number of micronuclei 
were present at 100 ug/ml of PHA, then dropped to 4/1000 
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was similar in the 100 Rand 50 R cultures. The greatest 
number of micronuclei were produced at 200 Rand 30 ug/ml 
of PHA, with a mean of 44/1000 lymphocytes. The number 
of micronuclei declined to 30/1000 lymphocytes with 100 
ug/ml of PHA, and, at 300 ug/ml of PHA, were within the 
range of response elicited at 10 ug/ml of PHA. 
Cell morphology changed with increasing concentration 
of PHA and increasing radiation. Control cultures 
without PHA contained 99% small lymphocytes. Morphologic 
integrity of the control cultures decreased as the 
radiation exposure increased. The control cultures at 
200 R contained more pyknotic small lymphocytes, and some 
cell debris was evident. There was no debris at the 
lower doses of radiation. Visual examination suggested 
that cell number increased in cultures that contained 
higher PHA concentrations. Lymphocytes exposed to PHA 
concentrations of 30 ug/ml or higher were 99% blast 
transformed. Many cells were observed in various stages 
of mitosis. Some cells, in which the spindle had already 
formed, had poorly defined and densely stained material 
that appeared to be lagging near the metaphase plate 
after the chromosomes were almost at the centromere. The 
fate of this nonspindle associated chromosomal material 
has not been determined. Cells observed in later stages 
of mitosis continued to reveal these areas, which 
appeared to become more dense. 
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PBML exposed to the highest radiation doses and 
cultured with the highest concentrations of PHA were 
larger than commonly observed blast cells, and some had 
disrupted membranes. The cytoplasm of these cells had a 
lacy appearance and stained a very pale blue. 
Agglutination was so extensive that individual cell 
morphology was difficult to distinguish. Micronuclei 
contained in these very large blast-transformed cells 
were also larger than the micronuclei seen in cultures 
with lower concentrations of PHA and irradiation. 
Figure 9 (Experiment B) is a graph representing 
tritiated thymidine (3HTdr) uptake in PBML cultured 
concomitantly with PBML treated for micronuclei 
production. These data indicate that DNA synthesis is 
not impaired or enhanced by radiation. Control cultures 
without PHA or radiation produced 666 cpm. Nonirradiated 
cells showed in increase in uptake of 3HTdr as counts 
rose to 1911 cpm at 3 ug/ml of PHA, 33,320 cpm at 10 
ug/ml of PHA, and peaking at 201,635 cpm at 300 ug/ml of 
PHA. 
Maximum DNA synthesis and micronuclei production were 
achieved at 30 ug/ml of PHA, regardless of the dose of 
radiation. However, DNA synthesis is not affected by 
radiation, as can be seen in Figure 9. The decline in 
numbers of micronuclei in irradiated PBML at higher than 
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Figure 9. Experiment B: DNA synthesis--3HTdr 
incorporation into DNA by PBML incubated with a range of 
concentrations of PHA following exposure to gamma 
radiation (50-200 R). 
uptake, indicating that it is unlikely that decreasing 
numbers of micronuclei are due to cell death. 
Interferon titers varied independently from 
micronuclei formation and tritiated thymidine into DNA. 
Figure 10 (Experiment B) shows there were less than 3 
units of interferon produced with no PHA or with 3 ug/ml 
of PHA. Interferon production was variable at 30 ug/ml 
of PHA, a concentration where maximum micronuclei were 
consistently produced. The highest titer of interferon 
was induced by 100 R, which produced 460 units of gamma 
interferon. Almost 100 units were induced in the non-
irradiated cultures. PBML exposed to 50 R produced 
increasingly higher titers of gamma interferon as PHA 
concentration increased to 300 ug/ml of PHA. The latter 
concentration of PHA induced the production of 550 units 
of gamma interferon. 
The data obtained in a subsequent experiment (Figure 
11, Experiment C) were consistent with the previous 
experiment in that peak micronuclei production was 
reached at 30 ug/ml of PHA and 200 R. The control 
cultures without PHA or radiation did not contain 
micronuclei. A mean of 1/1000 lymphocytes was counted in 
the nonirradiated cultures containing 10 ug/ml, 30 ug/ml, 
and 100 ug/ml of PHA. The 300 ug/ml of PHA cultures 
contained 5.5/1000 lymphocytes. As seen in the previous 
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Fig. 10. Gamma interferon production by PBML incubated 
with a range of concentrations of PHA following exposure 



































































































































































































































































































be no dose-response curve to PHA without radiation. A 
mean of 47/1000 lymphocytes was counted in the cultures 
containing 30 ug/ml of PHA and 200 R. All control 
cultures without PHA, regardless of radiation levels, 
contained no micronuclei. 
Tritiated thymidine incorporation into DNA increased 
with PHA concentration. These data are presented 
graphically in Figure 12 (Experiment C) and summarized in 
Table 2. The intensity of uptake of 3HTdr was similar to 
the prior experiment and was unaffected by radiation. 
Micronuclei production in the 200 R cultures did not 
decline as rapidly in this experiment; however, the 
number of micronuclei was less at 300 ug/ml of PHA. 
Interferon titers could not be determined in this 
experiment because of toxicity of the microculture 
plates. Toxicity in the plastic interfered with the 
growth of the WISH amnion monolayer. However, prelimin-
ary results indicated there were less than 3 units of 
interferon produced at all radiation exposures in the 
controls, 3 ug/ml, and 10 ug/ml of PHA. The higher 
concentrations of PHA induced greater than 100 units of 
interferon, but the results were highly variable, due to 
the toxicity. 
Results obtained in prior experiments were confirmed 
in an additional experiment, which assayed blood simul-
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Figure 12. Experiment C: DNA synthesis--3HTdr 
incorporation into DNA of PBML incubated wlth a range of 
concentrations of PHA following exposure to gamma 
radiation (50-200 R). 
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TABLE 2 
EXPERIMENTS BAND C: 3HTdr INCORPORATION 
INTO DNA OF LYMPHOCYTES (CPM) 
PHA Radiation (Rads) 
(ug/ml) 0 50 100 200 
Experiment B 
300 201635 147090 166374 167902 
100 161018 142530 161574 204483 
30 181164 103624 199441 235853 
10 33320 103624 199441 235853 
3 1911 3807 667 1997 
0 666 141 307 427 
Experiment C 
300 N.A. 297775 237761 259030 
100 N.A. 247180 263330 199998 
30 N.A. 186057 220816 160995 
10 N.A. 76834 98107 48184 
3 N.A. 1258 2475 4595 
0 N.A. 969 853 771 
as well as the 2 preceding experiments, are described in 
Sections 2.2 and 2.3. Figures 13 (Experiment D) and 14 
(Experiment E) are graphs of micronuclei production by 
PBML from the individual blood donors. Figures 15 
(Experiment D) and 16 (Experiment E) show the 3HTdr 
results obtained from the replicate cultures. Interferon 
data were not plotted because of continued toxicity 
problems and inconsistent data. 
There were no micronuclei in the nonPHA, nonirradi-
ated controls from Experiment D. There were also no 
micronuclei in all PHA controls. The nonirradiated 
cultures contained no micronuclei until a concentration 
of 30 ug/ml of PHA was reached, with a mean of 2.5/1000 
lymphocytes. Peak micronuclei production occurred with 
30 ug/ml of PHA and 200 R, where a mean of 55/1000 
lymphocytes was produced. 
Data obtained with PBML from Experiment E were 
similar to those for Experiment D and previous 
experiments. Similarities included no micronuclei in the 
control cultures and peak micronuclei production at 30 
ug/ml of PHA and 200 R, where a mean of 80/1000 lympho-
cytes were produced. Notes taken at the time that the 
code was broken indicated a similar observation as in 
Experiment D, that the blast transformed cells in the 
high radiation cultures appeared to be healthy, while the 
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Fig. 14. Experiment E: Micronuclei (mean ± S.D.) in 
PBML exposed to gamma radiation (50-200 R) and incubated 







20 40 60 80 100 300 
PHA ug.l ML 
Figure 15. Experiment D: DNA synthesis--3HTdr 
incorporation into DNA of PBML incubated with a range of 
concentrations of PHA following exposure to gamma 
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Figure 16. Experiment E: DNA synthesis--3HTdr 
incorporation into DNA of PBML incubated with a range of 
concentrations of PHA following exposure to gamma 
rad~ation (50-200 R). 
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It was also noted that the extreme blast transformation 
and agglutination in these high PHA concentration 
cultures made it difficult to identify micronuclei. It 
was necessary to look at the periphery of large, dense 
clumps of cells that contained more cells than could be 
counted. 
Tritiated thymidine uptake into DNA in Experiments D 
and E was similar to the two previous experiments in that 
radiation did not inhibit DNA synthesis. Uptake of 3HTdr 
increased with concentration of PHA and remained 
consistently high. These data are presented in Table 3. 
TABLE 3 
EXPERIMENTS D AND E: 3HTdr INCORPORATION 
INTO DNA OF LYMPHOCYTES (CPM) 
PHA Radiation (Rads) 






















































4. DISCUSSION AND SIGNIFICANCE 
The potential of the Micronucleus Test to measure 
genotoxicity has not yet been realized because of 
variable methodology and inadequate standardization. 
Also, current applications to epidemiologic studies of 
disease states have been based upon methodologies of 
uncertain reproducibility. Current applications, also, 
have not characterized differences between the mouse 
erythrocyte model and the human peripheral blood mono-
nuclear leukocyte model. Further differences might be 
seen in a newer human erythrocyte study being performed 
in asplenic human subjects (MacGregor). It is unclear 
the expression of a micronucleus in mouse or human 
erythrocytes is caused by the same process that is 
responsible for PBML micronuclei. Immature erythrocytes 
normally contain a micronucleus that, as the cell 
matures, is removed by the spleen. Since human PBML 
micronuclei are seen above background levels only when 
exposed to a genotoxic initiator and a blastogenic agent, 
it is entirely possible that the methodologies are not 
comparable. However, studies that could compare PBML 
micronuclei and human erythrocyte micronuclei might 
greatly expand the understanding of the role of the 
micronucleus in both systems. 
Comparison of data without standardization has 
resulted in conflicting and uncertain results. By 
contrast, the data presented in this paper, show that the 
number of micronuclei produced is related to concentra-
tion of both the genotoxin (radiation) and the 
blastogenic agent (PHA). These variables and 
qualifications have been incorporated into standardized 
protocols, which generate reproducible results. A major 
contribution of this study lies in the application of 
standardized methods to a biologic phenomenon that can be 
precisely measured. Data between laboratories can be 
compared and multiple parameters can be studied 
concurrently. 
Information obtained in the course of experiments to 
standardize the micronucleus assay provided some 
potentially important insights into the mechanisms of 
micronucleus formation. Previously, an understanding of 
mechanisms of micronucleus formation was limited by the 
methods employed. In some studies specific concentra-
tions of a genotoxic agent were added directly to cells. 
In other experiments, cells were exposed to radiation. A 
limited number of studies used blood or bone marrow cells 
examined from individuals who were exposed to a 
genotoxin. A common belief based on indirect evidence 
was that the genotoxin was the major contributor to 
induction of the micronuclei. Data presented here, which 
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are based on direct experimental observation, indicate 
this is not the case. Human peripheral blood mononuclear 
leukocytes do not produce micronuclei, even after 
genotoxic exposure, unless they are induced to blast 
transform. 
The current work also documents that micronuclei 
formation is PHA dose-dependent. No micronuclei are 
observed in small, nonblast transformed cells. This PHA 
dose dependency becomes more apparent when PBML have been 
exposed to a genotoxin, in this study, radiation. Thus, 
no dose-response relationship exists when PBML are 
treated with various concentrations of PHA without prior 
radiation exposure. As an example, Table 4 demonstrates 
that, without radiation exposure, no greater than 6/1000 
cells were ever induced in a culture. However, as many 
as 80/1000 cells were induced when radiation was combined 
with PHA. 
The importance of the dose-dependent relationship of 
micronucleus induction with PHA evolves from the recogni-
tion that use of too small a concentration of PHA can 
drastically minimize the ability to identify a substance 
as genotoxic. Also, the arbitrary use of too great a 
concentration of PHA can produce the same result. 
Furthermore, excessively high PHA concentrations produce 
extensive agglutination, which renders large portions of 


























































































































































































































































































An example of the importance of PHA concentration is 
seen in Figure 14. PBML exposed to 200 Rand 30 ug/ml of 
PHA produced 80/1000 lymphocytes, while the combination 
of 200 Rand 10 ug/ml of PHA produced fewer than 4/1000 
lymphocytes. If only 10 ug/ml of PHA had been added to 
the cultures, it would be reasonable to conclude that 200 
R only induced background numbers of micronuclei. In the 
absence of these precautions, using the micronucleus 
assay, one could conclude that radiation is not a 
genotoxin. 
The source of the misinformation that led previous 
investigators to use a single dose of PHA cannot be 
determined absolutely. Information supplied by PHA 
manufacturers may have contributed to the use of a single 
PHA dose. As an example, the package insert from 
Burroughs-Wellcome recommends that 900 ug/ml of PH A be 
added to PBML for chromosome analysis (Burroughs-
Wellcome). 
As shown in this study, the selection of certain 
concentrations must be based upon experimentation that 
directly measures what is being studied. Assays based 
upon the use of a single concentration of PHA, as seen in 
virtually all published work studying micronuclei, is not 
sufficient for assessing genotoxicity. 
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Surprisingly, results of the current studies 
demonstrate that PHA protects small lymphocytes from the 
lethal effects of radiation. The absolute dependence of 
micronuclei formation on PHA stimulation may arise, in 
part, from its ability to protect cells from the lethal 
effects of radiation. Lymphoid cells survive because of 
PHA stimulation, and surviving cells produce micronuclei. 
Data supporting this hypothesis come from several 
sources. Cellular debris was uniformly present in gamma-
irradiated PBML cultures to which little or no PHA had 
been added. It was noted consistently that small 
lymphocytes were selectively destroyed in cultures that 
contained both blast-transformed and untransformed cells. 
In these mixed cultures, surviving blast-transformed 
PBMLs appeared healthy. The relevance of this observa-
tion and the possible radioprotective state conferred by 
blastogenesis are worthy of further study. 
It was initially suspected that the drop in numbers 
of micronuclei at higher concentrations of PHA indicated 
cell death. Measurement of tritiated thymidine incorpor-
ation into DNA was chosen to measure cell function, 
because of the problems associated with trying to assess 
viability in massively agglutinated PBML. Figures 9, 12, 
15, and 16 display highly reproducible data obtained from 
4 separate donors measuring DNA synthesis. In each case 
maximum DNA synthesis occurred at 30 ug/ml of PHA, 
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regardless of exposure to radiation. These data indicate 
that significant radiation exposure (up to 200 R) does 
not suppress DNA synthesis in human PBML in the first SS 
hours following exposure. Also, no decrease in DNA 
synthesis occurs as PHA concentration increases. 
There are several potential explanations for the 
difference between DNA synthesis and micronuclei product-
ion. The absence of radiation-induced depression in DNA 
synthesis suggests that loss of cell viability is not the 
explanation for the decreased numbers of micronuclei. It 
has been suggested (Matter and Jaeger, 1975) that the 
cell dies following micronucleus formation. The absolute 
number of PBMLs containing micronuclei is relatively 
small and would not be noticed in cultures containing 
high concentrations of PHA that would produce extensive 
blast transformation. It would be reasonable to expect 
that cell debris would be present and noticed in cultures 
of dying cells, once they had produced many micronuclei. 
Debris was actually noted in cultures exposed to high 
radiation and that contained low concentrations of PHA. 
Micronuclei counting is a static process that may not 
accurately represent the results of the dynamic events of 
micronuclei formation and loss. One source of loss, as 
discussed in the preceding paragraphs, is the death of 
micronuclei-containing cells. Another possible explana-
tion for the decrease in micronuclei is that, after the 
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micronucleus is produced, it gradually moves toward the 
cytoplasmic membrane through which it is released. 
Micronuclei were observed very close to the main nucleus 
and well into the cytoplasm. Several in individual cells 
were observed at the membrane with an apparent bulge in 
the membrane. Interestingly, no micronuclei were seen 
outside the cell, nor have extracellular micronuclei been 
reported. It is uncertain that free micronuclei can be 
detected microscopically, since it is likely they would 
appear as debris. It is also questionable as to whether 
they could exist intact as extracellular entities or 
whether they would be degraded. Studies have not been 
performed to characterize the composition of micronuclei; 
therefore, their susceptibility to degradation is 
unknown. 
The expulsion of the micronucleus from the cell is 
consistent with a hypothesis that the micronucleus is 
formed in response to exposure to a genotoxic agent in an 
attempt to repair the nucleus. Successful repair is 
dependent upon intensity of damage to the DNA. It has 
been proposed that the micronucleus represents nuclear 
material that lagged behind during spindle formation. 
The nuclear material condenses into a micronucleus 
following cell division. Direct evidence to support this 
mechanism is not available in the literature. However, 
it seems plausible that, with recent evidence of repair 
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mechanisms in cells, the micronucleus is, in fact, 
nuclear material that is no longer needed by the cell 
(Maugh, 1984). Exposure to high concentrations of a 
genotoxic agent might inevitably lead to cell death, but 
would be preceded by an attempt at repair. 
The observation, on two separate occasions, of 
micronuclei in mitosis suggest that micronuclei retain 
some physiologic activity and can function independently 
from the main nucleus. Two micronuclei in separate 
experiments were observed in metaphase while the main 
nuclei of the cells were resting. The cells were intact, 
and the micronuclei were clearly defined and separated 
from the nucleus. It is not known if the dividing 
micronucleus within a resting lymphocyte yields two 
micronuclei within the cells. Likewise, the fate of 
"daughter" micronuclei is conjectural at this time. 
Daughter micronuclei may be expelled as part of a repair 
process or may represent mortal loss of information to 
the cell. The appearance of dividing micronuclei is 
unusual but suggests a much larger genetic role for the 
micronucleus than the common indicator of cell death. 
These observations raise questions that include the 
possibility that the accepted mechanism for production of 
micronuclei is incorrect and that micronuclei formation 
may be linked to the hypoploid state of many neoplastic 
cells. 
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The current studies also generated some preliminary 
information regarding gamma interferon production in 
relation to micronuclei formation by PBML. No gamma 
interferon was induced by radiation, regardless of the 
magnitude of exposure, until PHA concentrations of 30 
ug/ml or greater were reached. Interferon titers were 
not affected by radiation, and high titers of interferon 
were produced by PBML exposed to PHA and 100 Rand 200 R. 
The ability of the cell to produce gamma interferon and 
synthesize DNA under conditions of radiation-induced 
micronuclei formation can be interpreted in several ways: 




Cells that produce micronuclei are not the 
cells that make interferon and synthesize 
DNA. 
The sequence of events resulting in 
structural changes represented visually as 
micronuclei are more sensitive indicators 
of genotoxic damage than either 3HTdr 
uptake or gamma interferon production. 
Nuclear damage occurs after the 
transcription of the interferon genome for 
DNA has occurred and, therefore, has no 
effect on gamma interferon synthesis. 
3HTdr is incorporated into newly 
synthesized DNA, as well as radiation-
damaged DNA, which falsely suggests no 
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4 . 1 .5. 
damage, while interferon production 
declines as an accurate representation of 
radiation cell damage. 
Persistence of an intact interferon 
response in irradiated PBML cultures 
suggests that micronuclei formation may 
occur as part of a physiologic process of 
repair, as opposed to a pathologic process 
of cell degeneration and death. 
The modified micronucleus assay described in this 
paper has immediate application in several areas of both 
basic science and environmental medicine. The challenge 
to standardize this assay was not in the technical 
difficulty of the task but in understanding the role of 
contributing factors and quantitating their effects. 
With these considerations in mind, the assay has wide 
application. 
The major observations are that micronuclei 
production is a function of PHA and, by extension, other 
mitogen concentration; that without exposure to a 
genotoxic agent followed by stimulation with PHA, 
micronuclei production is not enhanced; that radiation 
damage to PBML appears to be markedly diminished with the 
introduction of PHA to the cultures; and that DNA 
synthesis is not affected by radiation exposure, regard-
less of PHA concentration. The task at hand is to use 
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this information to develop a clearer understanding of 
what biologic and environmental events will alter 
micronuclei formation, the physiological significance of 
micronuclei, the events leading to their formation and 
their ultimate fate, and whether these events represent 
repair and eventual return to normal function or to 
permanent damage and death. 
The descriptive methodology for a micronucleus assay, 
first introduced by Schmid, addressed the real need for 
accurately quantitating the effect of genotoxins on 
animals under actual conditions of environmental 
exposure. The ultimate objective was to be able to 
assess risks of genotoxic injury to humans. The results 
of the current studies suggest that modifications of the 
micronucleus test system can be applied with confidence 
to the study of genotoxic exposure in humans. 
Recognition of the importance of mitogen concentration 
can be used to develop assays that will provide data 
which can be reproduced between laboratories. These 
findings have been incorporated into an easily performed 
assay that uses existing microculture techniques. 
Acceptance of this approach to micronuclei quantitation 
will come if the standardization described in this paper 
can be demonstrated to be reproducible in situations in 
which its predecessors have failed. 
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